The hub genes identified in this study—such as CCL2, CD69, EGR2, and CCL20—may serve as candidate biomarkers indicating shared inflammatory or immune regulatory processes in HBV and TB (62, 98). The gene discussed is CCL20; the disease is tuberculosis.